Hantavirus Outbreak on Cruise Ship: Eight Cases, Three Deaths Confirmed
Key Developments
Eight cases of Andes virus hantavirus and three deaths have been confirmed on the Dutch-flagged MV Hondius cruise ship, operated by Oceanwide Expeditions. This marks the first recorded ship-borne cluster of the virus.
"This is not SARS-CoV-2. This is not the start of a COVID pandemic. This is an outbreak that we see on a ship." — Maria Van Kerkhove, WHO Acting Director for Epidemic and Pandemic Management
The index case, a Dutch man in his seventies, developed fever on April 6 and died aboard ship on April 11. The ship's doctor did not take samples or order isolation.
His wife disembarked on April 24, died in Johannesburg on April 26. South Africa confirmed hantavirus on April 27.
The Timeline of Events
- April 1: Cruise departs Ushuaia, Argentina, with 114 guests traveling via Antarctica to Cape Verde
- April 6: Index case develops fever
- April 11: Index case dies aboard ship; captain tells passengers death was due to non-infectious causes
- April 24: Index case's wife disembarks
- April 26: Wife dies in Johannesburg
- April 27: South Africa confirms hantavirus
- May 2: German woman dies aboard ship; WHO is informed — three weeks after the first death
Human-to-Human Transmission Confirmed
A German woman died aboard the ship on May 2. A British physician who cared for one of the cases is in intensive care.
A KLM flight attendant who had contact with a dying passenger has been hospitalized in Amsterdam with mild symptoms.
30 passengers had disembarked across four continents before the outbreak was known. No testing, quarantine, or notification was performed for these individuals. Oceanwide Expeditions eventually emailed disembarked passengers.
Official Responses
- WHO: Confirmed human-to-human transmission on the ship, but emphasized this is not a pandemic-level threat
- CDC–State Department (May 6): Declared risk to the American public "extremely low"
- Former White House COVID coordinator Ashish Jha: "For the broader public, this is not a huge concern... This is not like COVID or flu."
- NIH Director and Acting CDC Director Jay Bhattacharya: Has held no press conference
Critical Limitations and Risks
Risk Factor Details Mortality rate 38-40% (vs. ~1% for COVID-19) Treatment No FDA-approved vaccine or specific antiviral Incubation Can extend up to eight weeks Detection gap No testing, quarantine, or notification for disembarked passengersThe hantavirus strain carries a 38-40% case fatality rate — roughly 40 times that of COVID-19.
Broader Context
The outbreak comes amid significant changes to US public health infrastructure:
- The US withdrew from WHO in January 2025
- CDC's Vessel Sanitation Program was eliminated
- CDC's STOP Spillover program was eliminated
- HHS downsized by over 20,000 workers
- NIH budget cut from $47 billion to $27 billion